Beazley’s research found fewer than a third (30%) buy the essential...
Category:
Eco/Invest/Demography
Latest
Lloyd’s partners with World Bank Group in bid to boost guarantees to $20bn by 2030
Lloyd’s CEO, John Neal, said, “Collaboration is the hallmark of the...
Average health claim size rises 12% to Rs 70,558 in India in 2023-24: ACKO report
The average claim size in India for 2023-24 stands at ₹70,558, up...
“We reserve right to invoke provisions of law on misinformation on some comments made by Delhi CM”: Singapore envoy
”So indeed, in Singapore, there is an act called Protection from Online Falsehoods and Manipulation Act known as POFMA. It is meant to mitigate the spread of misinformation. So we reserve the right to invoke POFMA on some of the comments and assertions made by the Chief Minister on this topic,” Wong said.
57.25 lakh domestic air passengers in April, 26.8 pc lower than March: DGCA
According to the Directorate General of Civil Aviation (DGCA), 78.27 lakh people travelled by air within the country in February. The drop in domestic air traffic in April is due to the second wave of the pandemic that has badly hit India and its aviation sector.
IT Ministry directs WhatsApp to withdraw new privacy policy: Govt sources
The IT Ministry believes that the changes to WhatsApp privacy policy and the manner of introducing the said changes undermines the sacrosanct values of informational privacy, data security and user choice and harms the rights and interests of Indian citizens, government sources said.
The government has given seven days to WhatsApp to respond to the notice and if no satisfactory response is received, necessary steps in consonance with law will be taken, sources informed.
Facebook rolls out Covid announcement tool to help health depts in India
“The COVID-19 Announcement feature will give health departments the ability to push out timely, credible COVID-19 and vaccine information to people in their local communities/ state jurisdictions. States will be able to issue these alerts statewide or to specific cities within their state,” it added.
Vaccination should be taken 3 months after recovery from COVID-19: Health ministry
COVID-19 vaccination should be deferred by three months after recovery in individuals having lab test proven SARS-CoV-2 individuals having lab test proven SARS-2 COVID-19 illness, according to the statement. Also, vaccination in COVID-19 patients who have been given anti-SARS-2 monoclonal antibodies or convalescent plasma to be deferred by three months from the date of discharge from the hospital.
Drones to digital: Asia, Africa find ways to plug COVID health gaps
Telemedicine platform gives Pakistan’s women medics new e-avenue
* Indian youth on low incomes trained as skilled health workers
* Solar-powered freezers used for COVID vaccines in rural Kenya
Europe regulator sees first flying taxis in 2024 or 2025
More than half a dozen European firms have announced developments of Urban Air Mobility vehicles for passenger use or for unmanned cargo sorties such as delivering medical supplies. “I believe that commercial use of (air) taxis can start to take place in 2024 or 2025,” Patrick Ky, executive director of the European Union Aviation Safety Agency (EASA) said.
Land to be given for National Institute of Medicinal Plants in Sindhudurg district
The land, located in Aadali village of Dodamarg taluka, will be handed over to the Union AYUSH ministry.NIMP would be a ”one-stop center” for all matters related to medicinal plants and will work in coordination with the state and central government.
Less than 2 pc population affected by COVID in India, 98 pc still vulnerable: Govt
The government said that of the total population in India, 1.8 per cent has been affected by COVID-19 so far and 98 per cent of the population is still susceptible or vulnerable to the infection.
The government said a continued decline has been noted in active cases in the last 15 days. From 17.13 per cent of the total caseload reported on May 3, it has reduced to 13.3 per cent, it added.
Covaxin phase II/III clinical trials for 2-18 age group to begin in 10-12 days: Govt
“Covaxin has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years. I have been told that trials will begin in the next 10-12 days,” Paul said during a press conference.
Hours after Delhi Chief Minister Arvind Kejriwal stated that the new COVID variant detected in Singapore is “deadly for children” and may bring in third wave of the disease in the country, Paul reassured that children will not get serious COVID-19 infection, adding that the situation is being closely monitored and reports referring to the variant are being examined.